Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage
BACKGROUND: Although volume of intracerebral hemorrhage (ICH) is a predictor of mortality, it is unknown whether subsequent hematoma growth further increases the risk of death or poor functional outcome. - METHODS: To determine if hematoma growth independently predicts poor outcome, the authors perf...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
April 24, 2006
|
| In: |
Neurology
Year: 2006, Volume: 66, Issue: 8, Pages: 1175-1181 |
| ISSN: | 1526-632X |
| DOI: | 10.1212/01.wnl.0000208408.98482.99 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1212/01.wnl.0000208408.98482.99 |
| Author Notes: | S.M. Davis, J. Broderick, M. Hennerici, N.C. Brun, M.N. Diringer, S.A. Mayer, K. Begtrup, and T. Steiner, for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1801195072 | ||
| 003 | DE-627 | ||
| 005 | 20220820180004.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220509s2006 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1212/01.wnl.0000208408.98482.99 |2 doi | |
| 035 | |a (DE-627)1801195072 | ||
| 035 | |a (DE-599)KXP1801195072 | ||
| 035 | |a (OCoLC)1341459407 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Davis, Stephen |e VerfasserIn |0 (DE-588)1123982775 |0 (DE-627)877641927 |0 (DE-576)482220023 |4 aut | |
| 245 | 1 | 0 | |a Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage |c S.M. Davis, J. Broderick, M. Hennerici, N.C. Brun, M.N. Diringer, S.A. Mayer, K. Begtrup, and T. Steiner, for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators |
| 264 | 1 | |c April 24, 2006 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 09.05.2022 | ||
| 520 | |a BACKGROUND: Although volume of intracerebral hemorrhage (ICH) is a predictor of mortality, it is unknown whether subsequent hematoma growth further increases the risk of death or poor functional outcome. - METHODS: To determine if hematoma growth independently predicts poor outcome, the authors performed an individual meta-analysis of patients with spontaneous ICH who had CT within 3 hours of onset and 24-hour follow-up. Placebo patients were pooled from three trials investigating dosing, safety, and efficacy of rFVIIa (n = 115), and 103 patients from the Cincinnati study (total 218). Other baseline factors included age, gender, blood glucose, blood pressure, Glasgow Coma Score (GCS), intraventricular hemorrhage (IVH), and location. - RESULTS: Overall, 72.9% of patients exhibited some degree of hematoma growth. Percentage hematoma growth (hazard ratio [HR] 1.05 per 10% increase [95% CI: 1.03, 1.08; p < 0.0001]), initial ICH volume (HR 1.01 per mL [95% CI: 1.00, 1.02; p = 0.003]), GCS (HR 0.88 [95% CI: 0.81, 0.96; p = 0.003]), and IVH (HR 2.23 [95% CI: 1.25, 3.98; p = 0.007]) were all associated with increased mortality. Percentage growth (cumulative OR 0.84 [95% CI: 0.75, 0.92; p < 0.0001]), initial ICH volume (cumulative OR 0.94 [95% CI: 0.91, 0.97; p < 0.0001]), GCS (cumulative OR 1.46 [95% CI: 1.21, 1.82; p < 0.0001]), and age (cumulative OR 0.95 [95% CI: 0.92, 0.98; p = 0.0009]) predicted outcome modified Rankin Scale. Gender, location, blood glucose, and blood pressure did not predict outcomes. - CONCLUSIONS: Hematoma growth is an independent determinant of both mortality and functional outcome after intracerebral hemorrhage. Attenuation of growth is an important therapeutic strategy. | ||
| 650 | 4 | |a Aged | |
| 650 | 4 | |a Cerebral Hemorrhage | |
| 650 | 4 | |a Factor VII | |
| 650 | 4 | |a Factor VIIa | |
| 650 | 4 | |a Female | |
| 650 | 4 | |a Hematoma, Subdural | |
| 650 | 4 | |a Humans | |
| 650 | 4 | |a Male | |
| 650 | 4 | |a Prognosis | |
| 650 | 4 | |a Recombinant Proteins | |
| 650 | 4 | |a Risk Factors | |
| 650 | 4 | |a Tomography, X-Ray Computed | |
| 700 | 1 | |a Broderick, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hennerici, Michael G. |d 1948- |e VerfasserIn |0 (DE-588)11587545X |0 (DE-627)077527704 |0 (DE-576)290126444 |4 aut | |
| 700 | 1 | |a Brun, N. C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Diringer, M. N. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mayer, S. A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Begtrup, K. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Steiner, T. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neurology |d Philadelphia, Pa. : Wolters Kluwer, 1951 |g 66(2006), 8, Seite 1175-1181 |h Online-Ressource |w (DE-627)302718524 |w (DE-600)1491874-2 |w (DE-576)079876609 |x 1526-632X |7 nnas |a Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage |
| 773 | 1 | 8 | |g volume:66 |g year:2006 |g number:8 |g pages:1175-1181 |g extent:7 |a Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage |
| 856 | 4 | 0 | |u https://doi.org/10.1212/01.wnl.0000208408.98482.99 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220509 | ||
| 993 | |a Article | ||
| 994 | |a 2006 | ||
| 998 | |g 11587545X |a Hennerici, Michael G. |m 11587545X:Hennerici, Michael G. |d 60000 |d 62700 |d 60000 |e 60000PH11587545X |e 62700PH11587545X |e 60000PH11587545X |k 0/60000/ |k 1/60000/62700/ |k 0/60000/ |p 3 | ||
| 999 | |a KXP-PPN1801195072 |e 4130303236 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["S.M. Davis, J. Broderick, M. Hennerici, N.C. Brun, M.N. Diringer, S.A. Mayer, K. Begtrup, and T. Steiner, for the Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators"]},"origin":[{"dateIssuedDisp":"April 24, 2006","dateIssuedKey":"2006"}],"id":{"eki":["1801195072"],"doi":["10.1212/01.wnl.0000208408.98482.99"]},"physDesc":[{"extent":"7 S."}],"relHost":[{"origin":[{"publisherPlace":"Philadelphia, Pa. ; [Erscheinungsort nicht ermittelbar] ; Hagerstown, Md.","publisher":"Wolters Kluwer ; Ovid ; Lippincott Williams & Wilkins","dateIssuedKey":"1951","dateIssuedDisp":"1951-"}],"id":{"issn":["1526-632X"],"zdb":["1491874-2"],"eki":["302718524"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Neurology","subtitle":"official journal of the American Academy of Neurology","title_sort":"Neurology"}],"pubHistory":["1.1951 -"],"part":{"text":"66(2006), 8, Seite 1175-1181","volume":"66","extent":"7","year":"2006","issue":"8","pages":"1175-1181"},"note":["Gesehen am 12.12.23"],"disp":"Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhageNeurology","type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"recId":"302718524"}],"person":[{"family":"Davis","given":"Stephen","roleDisplay":"VerfasserIn","display":"Davis, Stephen","role":"aut"},{"display":"Broderick, J.","roleDisplay":"VerfasserIn","role":"aut","family":"Broderick","given":"J."},{"family":"Hennerici","given":"Michael G.","roleDisplay":"VerfasserIn","display":"Hennerici, Michael G.","role":"aut"},{"family":"Brun","given":"N. C.","roleDisplay":"VerfasserIn","display":"Brun, N. C.","role":"aut"},{"given":"M. N.","family":"Diringer","role":"aut","roleDisplay":"VerfasserIn","display":"Diringer, M. N."},{"given":"S. A.","family":"Mayer","role":"aut","roleDisplay":"VerfasserIn","display":"Mayer, S. A."},{"family":"Begtrup","given":"K.","roleDisplay":"VerfasserIn","display":"Begtrup, K.","role":"aut"},{"display":"Steiner, T.","roleDisplay":"VerfasserIn","role":"aut","family":"Steiner","given":"T."}],"title":[{"title":"Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage","title_sort":"Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage"}],"note":["Gesehen am 09.05.2022"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1801195072","language":["eng"]} | ||
| SRT | |a DAVISSTEPHHEMATOMAGR2420 | ||